DexCom, Inc. (DXCM)
USD 61.8
(-9.3%)
USD 61.8
(-9.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.69 Billion USD | 13.36% |
| 2022 | 1.49 Billion USD | 5.46% |
| 2021 | 1.41 Billion USD | 44.27% |
| 2020 | 980.6 Million USD | 24.25% |
| 2019 | 789.2 Million USD | -7.17% |
| 2018 | 850.2 Million USD | 59.03% |
| 2017 | 534.6 Million USD | 20.87% |
| 2016 | 442.3 Million USD | 31.83% |
| 2015 | 335.5 Million USD | 69.62% |
| 2014 | 197.8 Million USD | 53.33% |
| 2013 | 129 Million USD | 26.1% |
| 2012 | 102.3 Million USD | 26.79% |
| 2011 | 80.68 Million USD | 26.6% |
| 2010 | 63.73 Million USD | 28.77% |
| 2009 | 49.49 Million USD | 4.64% |
| 2008 | 47.29 Million USD | 22.64% |
| 2007 | 38.56 Million USD | -4.85% |
| 2006 | 40.53 Million USD | 24.98% |
| 2005 | 32.42 Million USD | 130.53% |
| 2004 | 14.06 Million USD | 38.12% |
| 2003 | 10.18 Million USD | 61.38% |
| 2002 | 6.31 Million USD | -6.14% |
| 2001 | 6.72 Million USD | 67.51% |
| 2000 | 4.01 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 468.7 Million USD | 1.71% |
| 2024 Q3 | 441.8 Million USD | -5.74% |
| 2024 Q1 | 460.8 Million USD | 4.8% |
| 2023 Q4 | 439.7 Million USD | 5.24% |
| 2023 Q1 | 415.4 Million USD | -0.12% |
| 2023 Q2 | 418.3 Million USD | 0.7% |
| 2023 Q3 | 417.8 Million USD | -0.12% |
| 2023 FY | 1.69 Billion USD | 13.36% |
| 2022 Q4 | 415.9 Million USD | 19.96% |
| 2022 FY | 1.49 Billion USD | 5.46% |
| 2022 Q1 | 356.8 Million USD | -24.41% |
| 2022 Q2 | 372.5 Million USD | 4.4% |
| 2022 Q3 | 346.7 Million USD | -6.93% |
| 2021 Q2 | 316.1 Million USD | 6.07% |
| 2021 Q3 | 328.6 Million USD | 3.95% |
| 2021 Q1 | 298 Million USD | 0.98% |
| 2021 FY | 1.41 Billion USD | 44.27% |
| 2021 Q4 | 472 Million USD | 43.64% |
| 2020 Q4 | 295.1 Million USD | 19.81% |
| 2020 Q1 | 222.9 Million USD | 7.27% |
| 2020 Q3 | 246.3 Million USD | 13.87% |
| 2020 FY | 980.6 Million USD | 24.25% |
| 2020 Q2 | 216.3 Million USD | -2.96% |
| 2019 Q2 | 207.3 Million USD | 13.16% |
| 2019 FY | 789.2 Million USD | -7.17% |
| 2019 Q4 | 207.8 Million USD | 8.85% |
| 2019 Q1 | 183.2 Million USD | -52.71% |
| 2019 Q3 | 190.9 Million USD | -7.91% |
| 2018 FY | 850.2 Million USD | 59.03% |
| 2018 Q1 | 149.6 Million USD | 5.72% |
| 2018 Q2 | 158.5 Million USD | 5.95% |
| 2018 Q3 | 154.7 Million USD | -2.4% |
| 2018 Q4 | 387.4 Million USD | 150.42% |
| 2017 Q2 | 131.1 Million USD | -2.53% |
| 2017 Q3 | 127.5 Million USD | -2.75% |
| 2017 FY | 534.6 Million USD | 20.87% |
| 2017 Q4 | 141.5 Million USD | 10.98% |
| 2017 Q1 | 134.5 Million USD | 9.53% |
| 2016 Q3 | 119.6 Million USD | 13.26% |
| 2016 Q2 | 105.6 Million USD | 11.98% |
| 2016 Q4 | 122.8 Million USD | 2.68% |
| 2016 FY | 442.3 Million USD | 31.83% |
| 2016 Q1 | 94.3 Million USD | 5.25% |
| 2015 FY | 335.5 Million USD | 69.62% |
| 2015 Q4 | 89.6 Million USD | -23.48% |
| 2015 Q3 | 117.1 Million USD | 68.25% |
| 2015 Q2 | 69.6 Million USD | 17.57% |
| 2015 Q1 | 59.2 Million USD | 2.42% |
| 2014 Q3 | 52.2 Million USD | 14.22% |
| 2014 Q4 | 57.8 Million USD | 10.73% |
| 2014 FY | 197.8 Million USD | 53.33% |
| 2014 Q1 | 42.1 Million USD | 15.66% |
| 2014 Q2 | 45.7 Million USD | 8.55% |
| 2013 FY | 129 Million USD | 26.1% |
| 2013 Q4 | 36.4 Million USD | 8.98% |
| 2013 Q2 | 31.8 Million USD | 16.06% |
| 2013 Q1 | 27.4 Million USD | 5.79% |
| 2013 Q3 | 33.4 Million USD | 5.03% |
| 2012 Q3 | 25.72 Million USD | -0.65% |
| 2012 Q2 | 25.89 Million USD | 4.47% |
| 2012 Q1 | 24.78 Million USD | 7.9% |
| 2012 FY | 102.3 Million USD | 26.79% |
| 2012 Q4 | 25.9 Million USD | 0.68% |
| 2011 Q4 | 22.96 Million USD | 6.97% |
| 2011 Q3 | 21.47 Million USD | 11.48% |
| 2011 Q2 | 19.26 Million USD | 13.39% |
| 2011 Q1 | 16.98 Million USD | 0.66% |
| 2011 FY | 80.68 Million USD | 26.6% |
| 2010 Q2 | 15.78 Million USD | 8.63% |
| 2010 Q1 | 14.53 Million USD | 7.1% |
| 2010 Q4 | 16.87 Million USD | 2.04% |
| 2010 Q3 | 16.53 Million USD | 4.76% |
| 2010 FY | 63.73 Million USD | 28.77% |
| 2009 Q3 | 12.44 Million USD | 0.3% |
| 2009 FY | 49.49 Million USD | 4.64% |
| 2009 Q4 | 13.56 Million USD | 9.04% |
| 2009 Q2 | 12.4 Million USD | 12.04% |
| 2009 Q1 | 11.07 Million USD | -7.1% |
| 2008 Q4 | 11.92 Million USD | -1.24% |
| 2008 FY | 47.29 Million USD | 22.64% |
| 2008 Q2 | 12.04 Million USD | 6.92% |
| 2008 Q1 | 11.26 Million USD | 12.08% |
| 2008 Q3 | 12.07 Million USD | 0.22% |
| 2007 Q1 | 9.4 Million USD | 2.31% |
| 2007 Q2 | 9.49 Million USD | 0.97% |
| 2007 Q3 | 9.61 Million USD | 1.23% |
| 2007 Q4 | 10.05 Million USD | 4.54% |
| 2007 FY | 38.56 Million USD | -4.85% |
| 2006 Q4 | 9.19 Million USD | -21.48% |
| 2006 FY | 40.53 Million USD | 24.98% |
| 2006 Q3 | 11.7 Million USD | 13.74% |
| 2006 Q2 | 10.29 Million USD | 10.26% |
| 2006 Q1 | 9.33 Million USD | -25.94% |
| 2005 Q1 | 6.12 Million USD | 0.0% |
| 2005 Q4 | 12.6 Million USD | 83.71% |
| 2005 Q3 | 6.86 Million USD | 0.28% |
| 2005 Q2 | 6.84 Million USD | 11.77% |
| 2005 FY | 32.42 Million USD | 130.53% |
| 2004 FY | 14.06 Million USD | 38.12% |
| 2003 FY | 10.18 Million USD | 61.38% |
| 2002 FY | 6.31 Million USD | -6.14% |
| 2001 FY | 6.72 Million USD | 67.51% |
| 2000 FY | 4.01 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -14967.712% |
| Cerus Corporation | 143.15 Million USD | -1081.377% |
| OrthoPediatrics Corp. | 137.01 Million USD | -1134.281% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -14786.189% |
| Talis Biomedical Corporation | 67.18 Million USD | -2417.191% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -6679.444% |
| Inogen, Inc. | 236.08 Million USD | -616.352% |
| Spectral AI, Inc. | 20.86 Million USD | -8005.828% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -2920.162% |
| CVRx, Inc. | 76.14 Million USD | -2121.113% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -47836.562% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -13441.517% |
| Orthofix Medical Inc. | 667.42 Million USD | -153.391% |
| Venus Concept Inc. | 80.47 Million USD | -2001.496% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -2889.148% |
| Bioventus Inc. | 409.91 Million USD | -312.57% |
| BrainsWay Ltd. | 28.01 Million USD | -5936.12% |
| Envoy Medical, Inc. | 17.89 Million USD | -9349.1% |
| electroCore, Inc. | 32.03 Million USD | -5179.885% |
| IceCure Medical Ltd | 16.87 Million USD | -9921.332% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -3885.671% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -9491.092% |
| MaxCyte, Inc. | 84.84 Million USD | -1893.282% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -13525.779% |
| Nexalin Technology, Inc. | 5.78 Million USD | -29152.653% |
| PAVmed Inc | 64.82 Million USD | -2508.79% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -3211.015% |
| RxSight, Inc. | 103.85 Million USD | -1528.503% |
| Sight Sciences, Inc. | 126.44 Million USD | -1237.456% |
| SI-BONE, Inc. | 156.35 Million USD | -981.669% |
| TELA Bio, Inc. | 84.18 Million USD | -1908.861% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -2314.069% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -731.608% |
| LivaNova PLC | 843.54 Million USD | -100.487% |
| 908 Devices Inc. | 68.08 Million USD | -2384.136% |
| Alphatec Holdings, Inc. | 483.59 Million USD | -249.712% |
| Nemaura Medical Inc. | 7.13 Million USD | -23590.246% |
| NeuroPace, Inc. | 75.29 Million USD | -2146.069% |
| LENSAR, Inc. | 33.33 Million USD | -4973.194% |
| Apyx Medical Corporation | 51.01 Million USD | -3214.908% |
| Cutera, Inc. | 197.72 Million USD | -755.334% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -6724.583% |
| BioSig Technologies, Inc. | 28.53 Million USD | -5827.795% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -783.248% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -4589.961% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | -102.202% |
| Axonics, Inc. | 270.2 Million USD | -525.902% |
| Outset Medical, Inc. | 198.77 Million USD | -750.833% |
| IRIDEX Corporation | 31.81 Million USD | -5215.899% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -838.414% |
| IRadimed Corporation | 30.12 Million USD | -5514.35% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -19721.847% |
| INVO Bioscience, Inc. | 7.85 Million USD | -21434.915% |
| Telesis Bio, Inc. | 63.48 Million USD | -2563.769% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -1617.774% |
| Varex Imaging Corporation | 224.8 Million USD | -652.313% |
| Quipt Home Medical Corp. | 148.66 Million USD | -1037.576% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -14326.341% |
| Pulmonx Corporation | 112.68 Million USD | -1400.794% |
| Dynatronics Corporation | 9.9 Million USD | -16968.99% |
| Modular Medical, Inc. | 17.52 Million USD | -9548.012% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -8277.669% |
| Semler Scientific, Inc. | 38.94 Million USD | -4242.646% |
| InMode Ltd. | 215.68 Million USD | -684.125% |
| Bruker Corporation | 1.07 Billion USD | -57.116% |
| Cytosorbents Corporation | 48.33 Million USD | -3398.78% |
| Align Technology, Inc. | 2.07 Billion USD | 18.568% |
| Viveve Medical, Inc. | 22.17 Million USD | -7527.294% |
| ZimVie Inc. | 275.12 Million USD | -514.7% |
| Movano Inc. | 29.69 Million USD | -5596.194% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -1132.016% |
| Nexalin Technology, Inc. | 5.78 Million USD | -29152.653% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -47836.562% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | -181.435% |
| Profound Medical Corp. | 33.6 Million USD | -4932.862% |
| Insulet Corporation | 939.9 Million USD | -79.934% |
| enVVeno Medical Corporation | 25.23 Million USD | -6601.006% |
| Surmodics, Inc. | 98.69 Million USD | -1613.527% |
| iCAD, Inc. | 22.22 Million USD | -7509.449% |
| Nuwellis, Inc. | 22.61 Million USD | -7378.884% |
| Biotricity, Inc. | 17.18 Million USD | -9741.398% |
| iRhythm Technologies, Inc. | 445.88 Million USD | -279.287% |
| Aethlon Medical, Inc. | 12.27 Million USD | -13674.779% |
| InspireMD, Inc. | 22.95 Million USD | -7269.063% |
| PAVmed Inc. | 64.82 Million USD | -2508.79% |
| BIOLASE, Inc. | 34.66 Million USD | -4779.259% |
| Beyond Air, Inc. | 61.7 Million USD | -2641.005% |
| FONAR Corporation | 28.6 Million USD | -5812.319% |
| AxoGen, Inc. | 149.33 Million USD | -1032.48% |
| Vivani Medical, Inc. | 26.96 Million USD | -6171.834% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -854.984% |
| Inari Medical, Inc. | 448.59 Million USD | -276.998% |
| UFP Technologies, Inc. | 58.08 Million USD | -2811.395% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -34220.975% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -26666.74% |
| Tenon Medical, Inc. | 16.96 Million USD | -9866.997% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -22775.693% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -3734.673% |
| AdaptHealth Corp. | 1.07 Billion USD | -56.888% |
| Sintx Technologies, Inc. | 15.2 Million USD | -11025.584% |
| NanoVibronix, Inc. | 4.97 Million USD | -33907.641% |
| Quanterix Corporation | 118.1 Million USD | -1332.007% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -14326.341% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -11610.289% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | -330.697% |
| TransMedics Group, Inc. | 182.82 Million USD | -825.063% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -5926.011% |
| NeuroMetrix, Inc. | 11.09 Million USD | -15137.499% |
| Hyperfine, Inc. | 52.87 Million USD | -3098.668% |
| Establishment Labs Holdings Inc. | 172 Million USD | -883.239% |
| Biomerica, Inc. | 6.97 Million USD | -24136.171% |
| Bone Biologics Corporation | 9.42 Million USD | -17837.48% |
| AVITA Medical, Inc. | 80.77 Million USD | -1993.608% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -16301.557% |
| Silk Road Medical, Inc | 186.35 Million USD | -807.505% |